- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06076902
Patch Study (Patch-augmented Rotator Cuff Repair)
Patch Study: a Single-center, Prospective, Single-blind, Randomized, Two-arm Controlled Study of Outcomes Following Synthetic Polyester Patch-augmented Rotator Cuff Repair
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This single-center, prospective, randomized controlled study will compare patients allocated to two treatment arms who are undergoing surgery to repair rotator cuff tears: (1) arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch, and (2) arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch. The primary objective is to compare complications (primarily retear rates) and the secondary objective is to compare mid- and long-term clinical and radiological outcomes using standard orthopedic assessments, such as the subjective shoulder value and the Constant-Murley score.
The Pitch-Patch is a single-use synthetic polyester patch (Pitch-Patch, neoligamentsTM, Leeds, UK) intended to reinforce the rotator cuff following or during repair by sutures or suture anchors where weakness exists in the soft tissue. The surgical group will be randomly assigned, and each group will include 150 patients. After surgery, patients will be followed for two years and undergo clinical and radiological assessments.
The main research question to be answered by this investigation is whether synthetic patch augmentation can significantly improve outcomes in patients with rotator cuff tears from either degenerative or traumatic origins versus patients with no patch augmentation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Florian Hess, MD
- Phone Number: +41 58 144 8143
- Email: florian.hess@stgag.ch
Study Locations
-
-
Thurgau
-
Frauenfeld, Thurgau, Switzerland, 8501
- Recruiting
- Spital Thurgau AG
-
Contact:
- Florian Hess, MD
- Phone Number: +41 58 144 8143
- Email: florian.hess@stgag.ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults with massive rotator cuff tear
- Tear must affect at least two tendons
- Primary surgery only
- Origin of tear can be either degenerative or traumatic
- German language speaking
Exclusion Criteria:
- Fatty infiltration grade 4 (according to Goutallier)
- Bilateral tears
- Cases of arthritis or severe osteoarthritis
- Structural or pathological condition of the bone or soft tissue that could impair healing
- Unable or unwilling to restrict activities to prescribed levels or follow rehabilitation guidelines
- Unable or unwilling to give consent (language barrier or cognitive impairment)
- Unwilling or unable to be assessed at 1- and 2-year follow-up assessment visits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment group with patch augmentation
Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch
|
The Pitch-Patch is a single-use device intended to reinforce the rotator cuff following or during repair by sutures or suture anchors where weakness exists in the soft tissue.
Other Names:
|
Active Comparator: Comparison group without patch augmentation
Arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch
|
Arthroscopic rotator cuff reconstruction using fixation with anchors and no augmentation with a synthetic polyester patch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rotator cuff retear rate
Time Frame: Up to two years postoperative
|
Occurence of retear following rotator cuff reconstruction to treat massive tear (measured using radiological imaging/ultrasound)
|
Up to two years postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complication rate (adverse event greater than grade 2)
Time Frame: Up to two years postoperative
|
Development of postoperative complications following rotator cuff reconstruction to treat massive tear
|
Up to two years postoperative
|
Pain levels
Time Frame: Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)
|
During clinical assessments, patient reported pain levels will be measured using visual analogue scale (VAS); scale 0 (low) to 15 (high)
|
Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)
|
Healing rate
Time Frame: 6-week and 1-year exams (postoperative)
|
Using radiological imaging (ultrasound), healing of the rotator cuff tear will be monitored over time
|
6-week and 1-year exams (postoperative)
|
Range of motion
Time Frame: Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)
|
Clinical assessments of healing using the range of motion will be compared over time
|
Preoperative and postoperative (6 weeks, 3 months, 1- and 2-year follow-up visits)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Florian Hess, MD, Spital Thurgau AG
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ProjectID 2023-00238
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Tears
-
Xiros LtdNot yet recruitingRotator Cuff Tear | Rotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Tears of the Shoulder
-
Gazi UniversityRecruitingMassive Irreparable Rotator Cuff TearsTurkey
-
Parc de Salut MarHospital Clinic of Barcelona; Hospital Universitario Fundación Jiménez Díaz; Hospital... and other collaboratorsRecruitingShoulder Disease | Massive Rotator Cuff TearsSpain
-
The Cleveland ClinicRecruitingRotator Cuff Tears | Rotator Cuff RepairsUnited States
-
CONMED CorporationRecruitingRotator Cuff TearsUnited States
-
The University of Texas Health Science Center,...Skye BiologicsNot yet recruiting
-
Peking University Third HospitalRecruiting
-
Kaohsiung Veterans General Hospital.Recruiting
-
University of CalgaryRecruiting
-
Seoul National University Bundang HospitalMinistry of Health, Republic of KoreaRecruitingRotator Cuff TearsKorea, Republic of
Clinical Trials on Arthroscopic rotator cuff reconstruction using fixation with anchors augmented with a synthetic polyester patch (Pitch-Patch Tissue Reinforcement Device))
-
Etzel ClinicCompletedRotator Cuff Tear